» Articles » PMID: 38023635

Managing Common Ambulatory Conditions: Exploring Clinical Decision Making Performance Between Pharmacists and Family Physicians

Overview
Date 2023 Nov 29
PMID 38023635
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Prescribing is part of the expanded scope of practice for pharmacists in Alberta, Canada. Given these responsibilities, clinical decision making (the outcome from the diagnostic and therapeutic decision making process) is an essential skill for pharmacists. The current study compared diagnostic and therapeutic decision-making between Additional Prescribing Authority (APA) pharmacists and family physicians using a set of common ambulatory clinical cases that both practitioners could encounter in the community as part of their daily practice.

Objectives: To explore clinical decision making performance and behaviors between APA pharmacists and family physicians during the assessment and prescribing of common ambulatory conditions.

Methods: Eight written ambulatory clinical cases were developed by a panel of experts in both family medicine and pharmacy that were commonly encountered in both professions' daily practice. Participating APA pharmacists and family physicians reviewed the cases and responded with likely diagnoses, recommended treatments, and reported confidence in therapeutic choices. The responses of 18 APA pharmacists and 9 family physicians in community practices were analyzed.

Results: There were no significant differences in diagnostic accuracy, therapeutic accuracy, confidence in diagnostic choices, and confidence in therapeutic choices between APA pharmacists and family physicians to these common ambulatory presentations.

Conclusions: This study provides preliminary insights regarding the capabilities of pharmacists in the assessment of common ambulatory community conditions and suggests that APA pharmacists are making similar diagnostic and therapeutic decisions to family physicians. Future research could focus on examining the performance of pharmacists trained in different pharmacy education models, as well as their ability to provide clinical assessment in other specialties, or in more uncommon clinical scenarios.

References
1.
Poh E, McArthur A, Stephenson M, Roughead E . Effects of pharmacist prescribing on patient outcomes in the hospital setting: a systematic review. JBI Database System Rev Implement Rep. 2018; 16(9):1823-1873. DOI: 10.11124/JBISRIR-2017-003697. View

2.
Al Hamarneh Y, Johnston K, Marra C, Tsuyuki R . Pharmacist prescribing and care improves cardiovascular risk, but is it cost-effective? A cost-effectiveness analysis of the REACH study. Can Pharm J (Ott). 2019; 152(4):257-266. PMC: 6610508. DOI: 10.1177/1715163519851822. View

3.
Carter M, Chapman S, Watson M . Multiplicity and complexity: a qualitative exploration of influences on prescribing in UK general practice. BMJ Open. 2021; 11(1):e041460. PMC: 7802664. DOI: 10.1136/bmjopen-2020-041460. View

4.
Weeks G, George J, MacLure K, Stewart D . Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care. Cochrane Database Syst Rev. 2016; 11:CD011227. PMC: 6464275. DOI: 10.1002/14651858.CD011227.pub2. View

5.
Gregory P, Whyte B, Austin Z . How do community pharmacists make decisions? Results of an exploratory qualitative study in Ontario. Can Pharm J (Ott). 2016; 149(2):90-8. PMC: 4813515. DOI: 10.1177/1715163515625656. View